|
Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers |
journalArticle |
2015 |
Palussiere, J.; Lagarde, P.; Auperin, A.; Deschamps, F.; Chomy, F.; de Baere, T. |
|
Postoperative radiotherapy for non-small cell lung cancer |
journalArticle |
2016 |
Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists |
|
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
|
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors |
journalArticle |
2017 |
Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C. |
|
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers |
journalArticle |
2016 |
Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S. |
|
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
|
Long-term outcome of liver transplantation in childhood: A study of 20-year survivors |
journalArticle |
2018 |
Martinelli, J.; Habes, D.; Majed, L.; Guettier, C.; Gonzalès, E.; Linglart, A.; Larue, C.; Furlan, V.; Pariente, D.; Baujard, C.; Branchereau, S.; Gauthier, F.; Jacquemin, E.; Bernard, O. |
|
Statistical approaches for evaluating body composition markers in clinical cancer research |
journalArticle |
2017 |
Bayar, M. A.; Antoun, S.; Lanoy, E. |
|
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients |
journalArticle |
2016 |
Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F. |
|
Laryngo-esophageal Dysfunction-free Survival in a Preservation Protocol for T3 Laryngeal Squamous-cell Carcinoma |
journalArticle |
2016 |
Gorphe, P.; Matias, M.; Even, C.; Ferte, C.; Bidault, F.; Garcia, G.; Temam, S.; Nguyen, F.; Blanchard, P.; Tao, Y.; Janot, F. |
|
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
|
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study |
journalArticle |
2017 |
Colomba, E.; Le Teuff, G.; Eisen, T.; Stewart, G. D.; Fife, K.; Larkin, J.; Biondo, A.; Pickering, L.; Srinivasan, A.; Boyle, H.; Derosa, L.; Sternberg, C. N.; Recine, F.; Ralph, C.; Saldana, C.; Barthélémy, P.; Bernhard, J. C.; Gurney, H.; Verhoest, G.; Vauleon, E.; Bigot, P.; Berger, J.; Pfister, C.; Gravis, G.; Rodier, J. M.; Culine, S.; Caty, A.; Rolland, F.; Priou, F.; Escudier, B.; Albiges, L. |
|
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials |
journalArticle |
2016 |
Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I. |
|
A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents |
journalArticle |
2017 |
Azan, A.; Caspers, P. J.; Bakker Schut, T. C.; Roy, S.; Boutros, C.; Mateus, C.; Routier, E.; Besse, B.; Planchard, D.; Seck, A.; Kamsu Kom, N.; Tomasic, G.; Koljenovic, S.; Noordhoek Hegt, V.; Texier, M.; Lanoy, E.; Eggermont, A. M.; Paci, A.; Robert, C.; Puppels, G. J.; Mir, L. M. |
|
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] |
journalArticle |
2019 |
Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F. |
|
[Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?] |
journalArticle |
2018 |
Margier, J.; Baffert, S.; Le Corroller-Soriano, A. G. |
|
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial |
journalArticle |
2015 |
van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group |
|
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France |
journalArticle |
2015 |
Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I. |
|
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
|
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab |
journalArticle |
2017 |
Chaput, N.; Lepage, P.; Coutzac, C.; Soularue, E.; Le Roux, K.; Monot, C.; Boselli, L.; Routier, E.; Cassard, L.; Collins, M.; Vaysse, T.; Marthey, L.; Eggermont, A.; Asvatourian, V.; Lanoy, E.; Mateus, C.; Robert, C.; Carbonnel, F. |
|
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma |
journalArticle |
2019 |
Limkin, E. J.; Blanchard, P. |
|
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials |
journalArticle |
2018 |
Pistilli, B.; Mazouni, C.; Zingarello, A.; Faron, M.; Saghatchian, M.; Grynberg, M.; Spielmann, M.; Kerbrat, P.; Roche, H.; Lorgis, V.; Bachelot, T.; Campone, M.; Levy, C.; Goncalves, A.; Lesur, A.; Veyret, C.; Vanlemmens, L.; Lemonnier, J.; Delaloge, S. |
|
Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics |
journalArticle |
2016 |
Rococo, E.; Mazouni, C.; Or, Z.; Mobillion, V.; Koon Sun Pat, M.; Bonastre, J. |
|
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer |
journalArticle |
2016 |
Brambilla, E.; Le Teuff, G.; Marguet, S.; Lantuejoul, S.; Dunant, A.; Graziano, S.; Pirker, R.; Douillard, J. Y.; Le Chevalier, T.; Filipits, M.; Rosell, R.; Kratzke, R.; Popper, H.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Tsao, M. S. |
|
Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study |
journalArticle |
2015 |
Jacob, J.; Heymann, S.; Borget, I.; Dumas, I.; Riahi, E.; Maroun, P.; Ezra, P.; Roberti, E.; Rivera, S.; Deutsch, E.; Bourgier, C. |
|
[Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database] |
journalArticle |
2016 |
Freyer, G.; Scotte, F.; Borget, I.; Bruyas, A.; Vainchtock, A.; Chouaid, C. |
|
Biomarker Discovery and Validation: Statistical Considerations |
journalArticle |
2021 |
Fang-Shu Ou, PhD,a, Stefan Michiels, PhD,b Yu Shyr, PhD,c Alex A. Adjei, MD, PhD,d Ann L. Oberg, PhD |
|
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort |
journalArticle |
2015 |
Dartois, L.; Gauthier, E.; Heitzmann, J.; Baglietto, L.; Michiels, S.; Mesrine, S.; Boutron-Ruault, M. C.; Delaloge, S.; Ragusa, S.; Clavel-Chapelon, F.; Fagherazzi, G. |
|
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium |
journalArticle |
2017 |
Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X. |
|
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma |
journalArticle |
2016 |
Anota, A.; Boulin, M.; Dabakuyo-Yonli, S.; Hillon, P.; Cercueil, J. P.; Minello, A.; Jouve, J. L.; Paoletti, X.; Bedenne, L.; Guiu, B.; Bonnetain, F. |
|
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey |
journalArticle |
2016 |
Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N. |
|
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
|
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
|
Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer: A systematic review and pooled analysis |
journalArticle |
2017 |
Chebib, R.; Verlingue, L.; Cozic, N.; Faron, M.; Burtin, P.; Boige, V.; Hollebecque, A.; Malka, D. |
|
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab |
journalArticle |
2016 |
Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S. |
|
Comparative analysis of durable responders on immune checkpoint inhibitors (ICI) versus other systemic therapies: A meta-analysis of phase III trials |
journalArticle |
2018 |
Pons-Tostivint, Elvire; Latouche, Aurélien; Vaflard, Pauline; Ricci, Francesco; Loirat, Delphine; Sablin, Marie-Paule; Rouzier, Roman; Kamal, Maud; Morel, Claire; Lecerf, Charlotte; Servois, Vincent; Paoletti, Xavier; Le Tourneau, Christophe |
|
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data |
journalArticle |
2017 |
Yin, Jun; Paoletti, Xavier; Sargent, Daniel J; Mandrekar, Sumithra J |
|
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study |
journalArticle |
2016 |
Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C. |
|
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis |
journalArticle |
2016 |
Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative |
|
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial |
journalArticle |
2015 |
Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva |